These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11103621)

  • 21. [When should liver biopsy be considered? Slightly increased ALAT can indicate steatosis--but a histological test is necessary for prognosis].
    Danielsson A
    Lakartidningen; 2004 Sep; 101(38):2862. PubMed ID: 15485168
    [No Abstract]   [Full Text] [Related]  

  • 22. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers.
    Ahmed MH
    Scand J Gastroenterol; 2006 Mar; 41(3):372. PubMed ID: 16497631
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonalcoholic fatty liver disease: defining a common problem.
    Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Importance of hypertransaminasemia in blood donors. Study performed in patients of the Saint Thomas Hospital].
    Narváez E; de Lozano D; Perez Ferrari R
    Rev Med Panama; 1983 Jan; 8(1):45-9. PubMed ID: 6828781
    [No Abstract]   [Full Text] [Related]  

  • 25. [Diagnosis of hepatosis].
    Nöcker J; Hartleb O; Weidemann H
    Dtsch Z Verdau Stoffwechselkr; 1966 Feb; 25(6):349-54. PubMed ID: 5998358
    [No Abstract]   [Full Text] [Related]  

  • 26. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement.
    Dixon JB; Bhathal PS; O'Brien PE
    Obes Surg; 2006 Oct; 16(10):1278-86. PubMed ID: 17059735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver.
    Loguercio C; De Simone T; D'Auria MV; de Sio I; Federico A; Tuccillo C; Abbatecola AM; Del Vecchio Blanco C;
    Dig Liver Dis; 2004 Jun; 36(6):398-405. PubMed ID: 15248380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum transaminase activity in leprosy in relation to liver damage.
    Shivde AV; Junnarkar RV
    Int J Lepr Other Mycobact Dis; 1967; 35(3):366-74. PubMed ID: 5630357
    [No Abstract]   [Full Text] [Related]  

  • 29. Restriction of dietary calories, fat and iron improves non-alcoholic fatty liver disease.
    Yamamoto M; Iwasa M; Iwata K; Kaito M; Sugimoto R; Urawa N; Mifuji R; Konishi M; Kobayashi Y; Adachi Y
    J Gastroenterol Hepatol; 2007 Apr; 22(4):498-503. PubMed ID: 17376040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interpretation of hypertransaminasemia].
    Othmani S; Bahri M; Bahri M
    Tunis Med; 2002 May; 80(5):236-44. PubMed ID: 12534025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Increased serum transaminases following liver biopsy].
    Gros H
    Med Klin; 1973 Feb; 68(7):226. PubMed ID: 4701874
    [No Abstract]   [Full Text] [Related]  

  • 32. [Controlled double-blind study on the effectiveness and tolerability of a combination therapy in chronic alcoholic liver diseases].
    Fink M; Mader R; Bräuer H
    Fortschr Med; 1978 Jul; 96(28):1428-32. PubMed ID: 27436
    [No Abstract]   [Full Text] [Related]  

  • 33. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver biopsies of blood donors with elevated alanine aminotransferase (ALT).
    Reppun T; Jain A
    Hawaii Med J; 1985 Oct; 44(10):398, 400. PubMed ID: 4086288
    [No Abstract]   [Full Text] [Related]  

  • 35. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study.
    Huang MA; Greenson JK; Chao C; Anderson L; Peterman D; Jacobson J; Emick D; Lok AS; Conjeevaram HS
    Am J Gastroenterol; 2005 May; 100(5):1072-81. PubMed ID: 15842581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.
    Ekstedt M; Franzén LE; Holmqvist M; Bendtsen P; Mathiesen UL; Bodemar G; Kechagias S
    Scand J Gastroenterol; 2009; 44(3):366-74. PubMed ID: 19016382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apoptosis markers in liver biopsy of nonalcoholic steatohepatitis in pediatric patients.
    Valva P; De Matteo E; Galoppo M; Pedreira A; Giacove G; Lezama C; Marco I; Galoppo MC; Preciado MV
    Hum Pathol; 2008 Dec; 39(12):1816-22. PubMed ID: 18715620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis.
    Iacobellis A; Mangia A; Leandro G; Clemente R; Festa V; Attino V; Ricciardi R; Giacobbe A; Facciorusso D; Andriulli A
    Am J Gastroenterol; 2005 Apr; 100(4):868-73. PubMed ID: 15784034
    [No Abstract]   [Full Text] [Related]  

  • 39. [On the clinical picture of fatty degeneration of the liver and fatty liver].
    Teichmann W; Lindemann A
    Z Gesamte Inn Med; 1967 Sep; 22(17):509-14. PubMed ID: 5591413
    [No Abstract]   [Full Text] [Related]  

  • 40. Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence?
    Yu AS; Keeffe EB
    Am J Gastroenterol; 2003 May; 98(5):955-6. PubMed ID: 12809814
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.